Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
18,810,702
-
Total 13F shares
-
20,972,168
-
Share change
-
-80,983
-
Total reported value
-
$1,835,216,298
-
Price per share
-
$87.51
-
Number of holders
-
295
-
Value change
-
-$6,566,680
-
Number of buys
-
145
-
Number of sells
-
128
Institutional Holders of LEMAITRE VASCULAR INC - Common Stock (LMAT) as of Q3 2025
As of 30 Sep 2025,
LEMAITRE VASCULAR INC - Common Stock (LMAT) was held by
295 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,972,168 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Conestoga Capital Advisors, LLC, Copeland Capital Management, LLC, GENEVA CAPITAL MANAGEMENT LLC, FIRST TRUST ADVISORS LP, STATE STREET CORP, CONGRESS ASSET MANAGEMENT CO, PRICE T ROWE ASSOCIATES INC /MD/, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
295
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.